Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/1997
08/28/1997CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
08/27/1997EP0791592A2 Azetidines
08/27/1997EP0791577A1 Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them
08/27/1997EP0791355A1 Method of reducing tissue damage associated with ischemia
08/27/1997EP0791012A1 Peptides exhibiting oxytocin antagonistic activity
08/27/1997EP0790995A1 A method of treating urinary bladder dysfunctions
08/27/1997EP0790830A1 Trophinin and trophinin-assisting proteins
08/27/1997EP0790827A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
08/27/1997EP0790826A1 Dihydropyrimidines and uses thereof
08/27/1997EP0767660A4 Methods and formulations for modulating the human sexual response
08/27/1997CN1158123A Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes
08/27/1997CN1157719A Percutaneous applied medicine contained gestodene
08/26/1997US5661169 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them
08/26/1997US5661163 Treatment of benign prostatic hyperplasia
08/26/1997US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists
08/26/1997US5661129 Organic nitrates containing a disulfide group as cardiovascular agents
08/26/1997US5660813 Method of screening of angiotens in II type I receptor antagonists
08/22/1997CA2198176A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
08/21/1997WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
08/21/1997WO1997030045A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
08/21/1997WO1997030044A1 Quinazoline compounds
08/21/1997WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies
08/21/1997WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
08/21/1997WO1997029763A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
08/21/1997WO1997029762A1 Urogenital and intestinal compositions
08/21/1997WO1997029748A1 Substituted biphenyl isoxazole sulfonamides
08/21/1997WO1997029746A1 Inhibition of protein glycation and prevention of vasculopathy
08/21/1997WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers
08/21/1997WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
08/21/1997CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
08/21/1997CA2246371A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
08/21/1997CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
08/21/1997CA2245810A1 Urogenital and intestinal compositions
08/21/1997CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
08/21/1997CA2240043A1 Substituted biphenyl isoxazole sulfonamides
08/21/1997CA2230639A1 Zwitterionic compositions and methods as biological response modifiers
08/20/1997EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them
08/20/1997EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists
08/20/1997EP0789761A1 Human scf, a splice variant thereof, its pharmaceutical use
08/20/1997EP0789760A2 Enzymatic method for modification of recombinant polypeptides
08/20/1997EP0789713A1 Antibodies
08/20/1997EP0789690A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities
08/20/1997EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor
08/20/1997EP0579833B1 Ethanolamine derivatives with anti-pollakiuria activity
08/20/1997CN1157615A Heterocyclic tachykinin receptor antagonists
08/20/1997CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases
08/20/1997CN1035670C Method for preparing benzoheterocyclic compounds or its salt
08/19/1997US5658908 Opioid diarylmethylpiperazines and piperdines
08/19/1997US5658897 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents
08/19/1997US5658587 Transdermal patch
08/17/1997CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process
08/14/1997WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a)
08/14/1997WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon
08/14/1997WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists
08/13/1997EP0788799A2 LHRH-Antagonists in the treatment of fertility disorders
08/13/1997EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
08/13/1997EP0788513A1 Binding agents to cd23
08/13/1997EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy
08/13/1997EP0788357A1 A method of treating urinary bladder dysfunctions
08/13/1997EP0788305A1 Composition for inactivating irritants in fluids
08/13/1997EP0664811B1 Gestagenically active 19,11-bridged 4-estrenes
08/13/1997CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels
08/13/1997CN1156964A Novel Peptides
08/12/1997US5656639 Heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
08/07/1997WO1997028160A1 Endothelin receptor antagonists
08/07/1997WO1997028159A1 Endothelin receptor antagonists
08/07/1997WO1997028158A1 Endothelin receptor antagonists
08/07/1997WO1997028154A1 Endothelin receptor antagonists
08/07/1997WO1997028153A1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/07/1997WO1997027869A1 Method for treatment of benign prostatic hypertrophy
08/07/1997WO1997027868A1 Ovulation triggering drugs
08/07/1997CA2218398A1 Ovulation triggering drugs
08/06/1997EP0787122A2 Calcium receptor-active compounds
08/06/1997CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists
08/05/1997US5654445 Intermediates for renin inhibitors, hypotensive agents
08/05/1997US5654427 Protein kinase inhibitors
08/05/1997US5654297 Tricyclic thieno-azepine vasopressin antagonists
08/05/1997US5654290 Anticoagulant; antitumor agents; absorption by brain tissue
08/05/1997US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
07/1997
07/31/1997WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application
07/31/1997WO1997026890A1 Medicaments containing aromatic azo compounds
07/31/1997WO1997026876A1 Methods of increasing sphincter competence
07/31/1997WO1997015269A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
07/31/1997DE19602989A1 Arzneimittel, enthaltend aromatische Azoverbindungen A medicament containing aromatic azo compounds
07/31/1997CA2243958A1 Medicaments containing aromatic azo compounds
07/30/1997EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein
07/30/1997EP0785926A1 New carboxylic acid derivatives, their preparation and their use
07/30/1997EP0785792A1 Treatment of ovarian estrogen dependent conditions
07/30/1997EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
07/30/1997CN1155838A Indolinone compounds for the treatment of disease
07/30/1997CN1155538A Substituted imidogen sulfamide, its preparation, use and medicines containing the same
07/30/1997CN1155435A Medicine for curing calculus in human body
07/29/1997US5652246 Neurokinin receptor antagonists; nervous system disorders
07/29/1997US5652243 Modulating cellular response
07/29/1997US5651980 Methods of use of uncoated gel particles
07/24/1997WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS
07/24/1997WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE
07/24/1997WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS